“Porem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.”
Margaret Dugan, M.D., is the Chief Medical Officer at Schrödinger, where she is responsible for clinical and regulatory development of Schrödinger’s pipeline of wholly-owned programs. She is a board-certified medical oncologist and hematologist with over 30 years of experience in clinical practice, medical research, and drug development. Prior to joining Schrödinger, Margaret served as Chief Medical Officer of Dracen Pharmaceuticals, an oncology company. During her career, she has held roles of increasing responsibility, including serving as a senior vice president at Novartis, where she led oncology-focused global strategic drug development for approximately 16 years, including several regulatory filings and approvals. Margaret has also held medical and strategic consulting roles for Salarius Pharmaceuticals and Sonalasense Inc. and is currently a Board Director for BeiGene, a biotech company specializing in the development of cancer drugs.
